The repurposed antiparasitic drug at the center of a fierce public-health argument — trial evidence, off-label use, and the politics of a cheap pill.
Two cheap, decades-old antiparasitic drugs sit behind hundreds of preclinical cancer papers and almost no human trials. Here is the pharmacology researchers describe — cancer stem…
There is no approved dosing chart for these drugs in cancer — no trial has ever set one. Here is the dosing one physician has used with cancer coaching clients, the side effects h…
A dog dewormer, a lung cancer patient given under a 1% chance of survival, and a Stanford case series doctors were not allowed to recommend but published anyway. The human stories…